The sell-off in this medical diagnostic company is providing a buying opportunity.
Luminex Corporation’s (LMNX)
From Nate’s Notes
Though Luminex Corporation’s (LMNX) stock took a bit of a hit as part of the sell-off, I believe the fact that the current slide has, at least for now, managed to stop will above the low that was set as part of the “spike down” that occurred back in early August is a solid piece of evidence on the bullish side of the ledger for the stock, and thus, those of you who are still working on building up to being roughly 80% invested should certainly think about making Luminex one of your “first buys” this month.
LMNX is a strong buy under $28 and a buy under $32
Nate Pile, Nate’s Notes, www.NotWallStreet.com, 707-433-7903, October 12, 2018